Symbol="RARE"
AssetType="Common Stock"
Name="Ultragenyx"
Description="Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California."
CIK="1515673"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="60 LEVERONI COURT, NOVATO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2710133000"
EBITDA="-652508032"
PERatio="None"
PEGRatio="-0.24"
BookValue="1.806"
DividendPerShare="0"
DividendYield="0"
EPS="-10.62"
RevenuePerShareTTM="5.72"
ProfitMargin="-1.789"
OperatingMarginTTM="-1.67"
ReturnOnAssetsTTM="-0.32"
ReturnOnEquityTTM="-1.786"
RevenueTTM="402856000"
GrossProfitTTM="-370780000"
DilutedEPSTTM="-10.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.212"
AnalystTargetPrice="89.85"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.3"
PriceToBookRatio="6.8"
EVToRevenue="6.79"
EVToEBITDA="-3.744"
Beta="0.854"
num_52WeekHigh="54.98"
num_52WeekLow="33.36"
num_50DayMovingAverage="42.56"
num_200DayMovingAverage="42.95"
SharesOutstanding="71489000"
DividendDate="None"
ExDividendDate="None"
symbol="RARE"
open="36.51"
high="37.31"
low="36.32"
price="36.57"
volume="475515.00"
latest_trading_day="2023-08-29"
previous_close="36.68"
change="-0.11"
change_percent="-0.2999%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="609460"
Change_recent_avg="-0.07"
Delta_recent_avg="1.74"
Variance_recent_avg="0.87"
Change_ratio_recent_avg="-0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="493"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_negative_thumbnail_id_2="518"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="638"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_positive_thumbnail_id_2="956"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0118.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
